Join the hospitals improving patient care while saving money with the T2Sepsis Solution.
- The FDA-cleared T2Candida® Panel is being used today in approximately 130 hospitals internationally.
- The T2Sepsis Solution is powered by T2 Magnetic Resonance (T2MR®) technology that has been featured over 200 peer-reviewed publications.
Proven hospitals results include:
- Henry Ford Hospital (Detroit, MI, USA) reduced the median ICU length of stay per patient by 7 days and showed a trend in reducing total LOS by an average of 4 days per patient. The hospital was also able to reduce or discontinue antifungal therapy. These factors were seen as major contributors to a projected $2.3 million in annual savings.
- Lee Health System (Ft. Myers, FL, USA) realized length-of-stay savings of 7 days for positive patients and captured about $200 in savings per negative patient by rapidly discontinuing or de-escalating antifungal drug therapy.